Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Buy Ormat Technologies, Inc. (ORA)?

Page 1 of 2

Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don’t publish. Small cap stocks -especially when they are screened well- can generate substantial outperformance versus a boring index fund. That’s why we analyze the activity of those successful funds in these small-cap stocks. In the following paragraphs, we analyze Ormat Technologies, Inc. (NYSE:ORA) from the perspective of those successful funds.

Is Ormat Technologies, Inc. (NYSE:ORA) a healthy stock for your portfolio? Money managers are taking an optimistic view. The number of bullish hedge fund investments moved up by 2 lately. ORA was in 14 hedge funds’ portfolios at the end of the third quarter of 2016. There were 12 hedge funds in our database with ORA positions at the end of the previous quarter. At the end of this article we will also compare ORA to other stocks including Kennedy-Wilson Holdings Inc (NYSE:KW), Cal-Maine Foods Inc (NASDAQ:CALM), and Myriad Genetics, Inc. (NASDAQ:MYGN) to get a better sense of its popularity.

Follow Ormat Technologies Inc. (NYSE:ORA)
Trade (NYSE:ORA) Now!

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.

usa, photography, america, north, conservation, emissions, power, pollution, rocky, engineering, co, colorado, environmental, change, ecology, social, waste, ecosystem,

Joseph Sohm / Shutterstock.com

How have hedgies been trading Ormat Technologies, Inc. (NYSE:ORA)?

At Q3’s end, a total of 14 of the hedge funds tracked by Insider Monkey held long positions in this stock, a 17% rise from one quarter earlier, as hedge fund positions trends upward again. Below, you can check out the change in hedge fund sentiment towards ORA over the last 5 quarters. So, let’s review which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

HedgeFundSentimentChart

Of the funds tracked by Insider Monkey, Impax Asset Management, led by Ian Simm, holds the most valuable position in Ormat Technologies, Inc. (NYSE:ORA). Impax Asset Management has a $26 million position in the stock, comprising 1.2% of its 13F portfolio. Sitting at the No. 2 spot is Renaissance Technologies, founded by Jim Simons, which holds a $25.4 million position. Some other professional money managers that hold long positions encompass Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital, Mario Gabelli’s GAMCO Investors, and Glenn Russell Dubin’s Highbridge Capital Management. We should note that Impax Asset Management is among our list of the 100 best performing hedge funds which is based on the performance of their 13F long positions in non-microcap stocks.

Page 1 of 2
Loading...